Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $1,649 - $2,370
28 Added 18.67%
178 $11,000
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $2,143 - $3,141
-27 Reduced 15.25%
150 $12,000
Q1 2022

May 10, 2022

BUY
$86.42 - $109.81 $7,777 - $9,882
90 Added 103.45%
177 $19,000
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $1,562 - $1,876
17 Added 24.29%
87 $10,000
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $344 - $383
4 Added 6.06%
70 $7,000
Q1 2021

May 13, 2021

SELL
$71.83 - $95.48 $502 - $668
-7 Reduced 9.59%
66 $6,000
Q4 2020

Feb 08, 2021

SELL
$67.0 - $84.39 $3,149 - $3,966
-47 Reduced 39.17%
73 $5,000
Q3 2020

Nov 06, 2020

BUY
$55.23 - $79.93 $6,627 - $9,591
120 New
120 $9,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.